2025
Heterogeneous Tumor Profiles in Hepatocellular Carcinoma: An Example of Late Recurrences With Genetically Distinct Tumors Over a 10-Year Survival
Cao Y, Laurans M, Onyiuke I, Walther Z, Zhang X, Rose M, Taddei T. Heterogeneous Tumor Profiles in Hepatocellular Carcinoma: An Example of Late Recurrences With Genetically Distinct Tumors Over a 10-Year Survival. ACG Case Reports Journal 2025, 12: e01670. DOI: 10.14309/crj.0000000000001670.Peer-Reviewed Original ResearchHepatocellular carcinomaTumor profilingLate recurrenceNext-generation sequencingRuptured hepatocellular carcinomaMetastasis 3 yearsDistinct tumorsProlonged survivalGenetically distinct tumorsRecurrenceUnique caseTargeted mutationCarcinomaTumorClinical insightsSurvivalPresentationGenetic sequencesPatients
2024
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update
Gordan J, Kennedy E, Abou-Alfa G, Beal E, Finn R, Gade T, Goff L, Gupta S, Guy J, Hoang H, Iyer R, Jaiyesimi I, Jhawer M, Karippot A, Kaseb A, Kelley R, Kortmansky J, Leaf A, Remak W, Sohal D, Taddei T, Wilson Woods A, Yarchoan M, Rose M. Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update. Journal Of Clinical Oncology 2024, 42: 1830-1850. PMID: 38502889, DOI: 10.1200/jco.23.02745.Peer-Reviewed Original ResearchTyrosine kinase inhibitorsAdvanced hepatocellular carcinomaSecond-line therapyFirst-line treatmentRandomized controlled trialsHepatocellular carcinomaSystemic therapyFirst-lineChild-Pugh class A liver diseaseEastern Cooperative Oncology Group performance status 0Child-Pugh class A patientsSecond-line therapy optionsFirst-line settingPerformance status 0Third-line therapyFirst-line therapyClass A patientsEvidence-based guidelinesTolerated sorafenibStatus 0A patientsMechanism of actionTherapy optionsClinical decision-makingGuideline update
2012
EMR-linked cancer tracker facilitates lung and liver cancer care.
Taddei T, Hunnibell L, DeLorenzo A, Rosa M, Connery D, Vogel D, Garla V, Taylor C, Rose M. EMR-linked cancer tracker facilitates lung and liver cancer care. Journal Of Clinical Oncology 2012, 30: 77-77. DOI: 10.1200/jco.2012.30.34_suppl.77.Peer-Reviewed Original ResearchTracking systemAbnormal imagesLung cancerNatural language processing programNLP technologySurveillance featuresNLP systemsCancer careHepatocellular carcinomaLiver cancerVA Connecticut Healthcare SystemReporting functionsStage I/II lung cancerProcessing programCase discoveryLiver cancer careCare coordination programMultidisciplinary cancer careLive linkAccuracy of identificationElectronic medical recordsDaily operationsPatient informationRadiology reportsCare navigators
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply